Polymeric micelles and nanoemulsions as tumor-targeted drug carriers: Insight through intravital imaging
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference48 articles.
1. Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin;Matsumura;Br. J. Cancer,2004
2. Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer;Danson;Br. J. Cancer,2004
3. Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer;Kim;Ann. Oncol.,2007
4. Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies;Kim;Clin. Cancer Res.,2004
5. NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel;Hamaguchi;Br. J. Cancer,2005
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Structured adaptive boosting trees for detection of multicellular aggregates in fluorescence intravital microscopy;Microvascular Research;2024-11
2. Targeted drug release from stable and safe ultrasound-sensitive nanocarriers;Frontiers in Molecular Biosciences;2024-06-19
3. Enhancing breast cancer treatment: Comprehensive study of gefitinib-loaded poloxamer 407/TPGS mixed micelles through design, development, in-silico modelling, In-Vitro testing, and Ex-Vivo characterization;International Journal of Pharmaceutics;2024-05
4. Macauba oil carried by polymeric micelles reduces migration and proliferation of triple-negative breast cancer cells;RSC Pharmaceutics;2024
5. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation;Molecular Cancer;2023-10-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3